{"filing":{"accession_number":"0001493152-26-034018","cik":"0001725430","ticker":"INBS","company_name":"INTELLIGENT BIO SOLUTIONS INC.","form":"8-K","filing_date":"2026-07-21","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226034018/form8-k.htm"},"events":[{"id":18999,"run_id":17099,"accession_number":"0001493152-26-034018","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"The filing discloses completion of precision testing for the Company's Intelligent Fingerprinting Drug Screening System as part of its FDA 510(k) submission package. This is a material operational and regulatory milestone—the precision testing of over 1,600 tests across three production runs and three independent sites strengthens the pathway to FDA clearance and planned U.S. market entry in a multi-billion-dollar drug screening market. While the event is clearly operational/regulatory in nature and material to investors, it does not fit neatly into a specific named category (not a restatement, impairment, litigation, or other defined event type), making operational_other the most appropriate classification.","company_name":"INTELLIGENT BIO SOLUTIONS INC.","ticker":"INBS","filing_date":"2026-07-21","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":17972,"accession_number":"0001493152-26-034018","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The filing discloses completion of precision testing for the Company's Intelligent Fingerprinting Drug Screening System as part of its FDA 510(k) submission package. This is a material operational and regulatory milestone—the precision testing of over 1,600 tests across three production runs and three independent sites strengthens the pathway to FDA clearance and planned U.S. market entry in a multi-billion-dollar drug screening market. While the event is clearly operational/regulatory in nature and material to investors, it does not fit neatly into a specific named category (not a restatement, impairment, litigation, or other defined event type), making operational_other the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-21T12:51:37.641585+00:00","company_name":"INTELLIGENT BIO SOLUTIONS INC.","ticker":"INBS","filing_date":"2026-07-21"}]}